ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 225,66
0,85%
DAX
17 896,50
-0,14%
Brent Oil
83,915
0,34%
Bitcoin
59 310,40
0,32%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cocrystal Pharma Inc (COCP)

  7. Cocrystal Pharma Inc (COCP) Actualités

COCP Cocrystal Pharma Inc

1,59
0,06 (3,92%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cocrystal Pharma Inc COCP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,06 3,92% 1,59 00:31:55
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,53 1,52 1,59 1,59 1,53
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:00GLOBEEnrollment Completed in Phase 2a Study with Cocrystal..
28/3/202413:00GLOBECocrystal Pharma Reports 2023 Financial Results and Provides..
19/3/202413:00GLOBECocrystal Pharma Receives Pre-IND Responses from the FDA on..
01/3/202422:15EDGAR2Form 8-K - Current report
08/1/202414:00EDGAR2Form 8-K - Current report
04/1/202422:01EDGAR2Form 8-K - Current report
04/1/202414:00GLOBECocrystal Pharma Provides an Update on the Clinical..
02/1/202415:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/12/202323:00EDGAR2Form 8-K - Current report
06/12/202314:00EDGAR2Form 8-K - Current report
06/12/202314:00GLOBECocrystal Pharma Announces First-Patient-In for Phase 2a..
04/12/202314:00EDGAR2Form 8-K - Current report
29/11/202314:00EDGAR2Form 8-K - Current report
29/11/202314:00GLOBECocrystal Pharma Highlights its Novel Inhaled and Oral..
27/11/202314:00GLOBECocrystal Pharma to Present at the NobleCon 19 Conference on..
13/11/202314:15EDGAR2Form 8-K - Current report
13/11/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:00GLOBECocrystal Pharma Reports Third Quarter 2023 Financial..
09/11/202314:00GLOBECocrystal Pharma to Discuss Progress with Novel Inhaled and..
31/10/202313:00EDGAR2Form 8-K - Current report
31/10/202313:00GLOBECocrystal Pharma Receives UK MHRA Authorization to Initiate..
28/9/202314:00GLOBECocrystal Pharma Doses First Subjects in Clinical Study of..
05/9/202314:00GLOBECocrystal Pharma to Participate in the H.C. Wainwright..
16/8/202322:05EDGAR2Form 8-K - Current report
14/8/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:00GLOBECocrystal Pharma Reports Second Quarter 2023 Financial..
08/8/202314:00GLOBECocrystal Pharma Selects Novel Oral Protease Inhibitor..
20/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202314:00GLOBECocrystal Pharma Receives HREC Approval to Initiate Phase 1..
15/5/202314:00GLOBECocrystal Pharma Reports First Quarter 2023 Financial..
04/5/202322:05GLOBECocrystal Pharma Presents New Data from its CC-42344 Phase 1..

Dernières Valeurs Consultées

NASDAQ
COCP
Cocrystal Pharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés